Habits  >>  bupropion sustained-release  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bupropion sustained-release / Generic mfg.
NCT00143364: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Completed
3
1005
US
varenicline (CP-526,555)
Pfizer
Smoking Cessation
 
03/05
NCT00141206: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Completed
3
1005
US
varenicline (CP-526,555)
Pfizer
Smoking Cessation
 
04/05
ConNic3, NCT00894166: Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype

Completed
3
606
US
Nicotine Patches, NicoDermCQ, Nicotine patches, then bupropion & nicotine patches (Pre-Quit), Zyban, Nicotine patches, then varenicline (Pre-Quit), Chantix, Nicotine patches, then nicotine patches (Pre-Quit), Nicotine patches, then bupropion & nicotine patches (Post-Quit), Nicotine patches, then varenicline (Post-Quit), Nicotine patches, then nicotine patches (Post-Quit)
Duke University, Philip Morris USA, Inc.
Smoking Cessation
07/11
10/11
LiveForLife2, NCT01560507: Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Terminated
2/3
19
US
varenicline (Chantix), Chantix, varenicline, bupropion (Zyban), Zyban, bupropion, nicotine patches
Duke University, Philip Morris USA, Inc.
Cigarette Smoking, Nicotine Dependence
07/13
07/13

Download Options